SYRE Investing Cash Flow
Spyre Therapeutics Inc · Investing Cash Flow
SYRE Investing Cash Flow
Latest reported-$463.74Mperiod ending
SYRE Cash from Investing (-$221.00K → -$463.74M)
Annual investing cash flow
High-resolution chart · PNG
SYRE investing cash flow history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Investing Cash Flow (USD) |
|---|---|
| -143,475,000 | |
| -353,285,000 | |
| -108,393,000 | |
| 57,008,000 | |
| -22,619,000 | |
| -7,604,000 | |
| -1,739,000 | |
| -15,231,000 | |
| -22,529,000 | |
| -12,156,000 | |
| -4,014,000 | |
| -221,000 |